Emergent BioSolutions (EBS) Enterprise Value: 2010-2025
Historic Enterprise Value for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $221.4 million.
- Emergent BioSolutions' Enterprise Value fell 22.43% to $221.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$308.0 million, marking a year-over-year decrease of 1401.39%. This contributed to the annual value of $412.4 million for FY2024, which is 3116.21% up from last year.
- Emergent BioSolutions' Enterprise Value amounted to $221.4 million in Q3 2025, which was up 194.00% from $75.3 million recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Enterprise Value registered a high of $4.4 billion during Q1 2021, and its lowest value of -$53.4 million during Q4 2022.
- Over the past 3 years, Emergent BioSolutions' median Enterprise Value value was $111.3 million (recorded in 2025), while the average stood at $174.3 million.
- As far as peak fluctuations go, Emergent BioSolutions' Enterprise Value tumbled by 103.03% in 2022, and later surged by 3,116.21% in 2024.
- Quarterly analysis of 5 years shows Emergent BioSolutions' Enterprise Value stood at $1.8 billion in 2021, then tumbled by 103.03% to -$53.4 million in 2022, then spiked by 124.00% to $12.8 million in 2023, then soared by 3,116.21% to $412.4 million in 2024, then fell by 22.43% to $221.4 million in 2025.
- Its last three reported values are $221.4 million in Q3 2025, $75.3 million for Q2 2025, and $111.3 million during Q1 2025.